Product Information
FEBUXOSTAT 80 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.3159 per EA under NDC 43547029603. Its NADAC has been published 144 times since Nov 1, 2023.
FDA first approved this application on Mar 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
80 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547029603
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
FEBUXOSTATApproval Type
Generic (ANDA)
FDA Application
ANDA206266FDA Approved
3/28/2022
TE Code
AB
On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for FEBUXOSTAT 80 MG TABLET has been published 144 times since Nov 1, 2023, and over the history we have for it it has declined 51.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3159 per EA |
|---|---|
| All-time high | $0.6539 (Dec 13, 2023) |
| All-time low | $0.2636 (Feb 18, 2026) |
| 52-week high | $0.4494 |
| 52-week low | $0.2636 |
| Median price | $0.4594 |
| Average price | $0.4383 |
| Largest weekly change | +30.2% (Aug 21, 2024) |
| Weeks tracked | 144 |
| Tracking since | Nov 1, 2023 |
1W
N/A
1M
-4.2%
3M
-4.1%
6M
+9.0%
1Y
-29.7%
3Y
N/A
5Y
N/A
All
-51.1%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FEBUXOSTAT 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEBUXOSTAT 80 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.3159 per EA (NDC 43547029603), effective Jul 29, 2026.
How has the price of FEBUXOSTAT 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEBUXOSTAT 80 MG TABLET has declined 51.1%. It has been tracked across 144 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for FEBUXOSTAT 80 MG TABLET?
Since Nov 1, 2023, the NADAC for FEBUXOSTAT 80 MG TABLET has ranged from a low of $0.2636 (Feb 18, 2026) to a high of $0.6539 (Dec 13, 2023), with a median of $0.4594 per EA.
Are there cheaper alternatives to FEBUXOSTAT 80 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FEBUXOSTAT 80 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FEBUXOSTAT 80 MG TABLET?
FEBUXOSTAT 80 MG TABLET (NDC 43547029603) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.